Publication | Open Access
Randomized, double-blind, placebo-controlled, parallel-group trial of sirolimus for tocilizumab-resistant idiopathic multicentric Castleman disease
10
Citations
18
References
2020
Year
This study was registered with the Japan Registry of Clinical Trials as jRCT2071190029 on October 8, 2019.
| Year | Citations | |
|---|---|---|
Page 1
Page 1